Serum, the Indian drug maker, is putting its faith in a Covid-19 vaccine being developed at the University of Oxford by starting mass production before it has been declared ready for use.
It is a calculated risk backed by the deep pockets behind the world’s largest vaccine maker. Chairman Cyrus Poonawalla has a net worth of $10.6 billion and is known as India’s “vaccine king.”
His company hopes to produce 40 million doses of the vaccine by September, the same deadline by which Oxford is aiming to complete human trials of the ChAdOX1 vaccine.
About 1,100 people in Britain will be injected with the vaccine, as part of a trial funded by the British government that was started after promising re
•
Apr 30, 2020
